Reported 44,332 shares, down 5,025 (10.2%) from the prior quarter.
Reported value -1.6%; share count -10.2% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-06-30 | 3920703 |
| 2024-09-30 | 3229374 |
| 2024-12-31 | 0 |
| 2025-12-31 | 5116397 |
| 2026-03-31 | 4874365 |
| 2026-06-30 | 9243579 |
| 2026-09-30 | 9099586 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Reduced | 44,332 | -5,025 (-10.2%) | 0.94% | $9,099,586 | 2026-11-16 | |
| Q2 2026 | Reduced | 49,357 | -765 (-1.5%) | 0.82% | $9,243,579 | 2026-08-13 | |
| Q1 2026 | Reduced | 50,122 | -14,114 (-22.0%) | 0.56% | $4,874,365 | 2026-05-13 | |
| Q4 2025 | New | 64,236 | +64,236 (0.0%) | 0.57% | $5,116,397 | 2026-02-12 | |
| Q4 2024 | Reduced | 0 | -71,210 (-100.0%) | 0 | $0 | 2025-02-13 | |
| Q3 2024 | Reduced | 71,210 | -29,813 (-29.5%) | 0.48% | $3,229,374 | 2024-11-13 | |
| Q2 2024 | New | 101,023 | +101,023 (0.0%) | 0.64% | $3,920,703 | 2024-08-12 |
Who else reported the position
828 managers reported REVOLUTION MEDICINES INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 15,397,714 | +3,197,292 | 0.14% | $3,160,534,467 | 27 qtrs |
| BlackRock Inc | Added | 13,857,324 | +161,534 | 0.04% | $2,844,354,468 | 9 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 13,418,796 | -132,000 | 11.87% | $2,754,342,067 | 23 qtrs |
| BAKER BROS ADVISORS LP | Reduced | 10,637,318 | -806,039 | 10.38% | $2,183,415,893 | 23 qtrs |
| Darwin Global Management Ltd | Unchanged | 10,629,822 | 0 | 54.66% | $2,181,877,264 | 3 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 9,149,534 | +60,873 | 0.04% | $1,878,033,349 | 3 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 8,157,073 | -137,782 | 0.08% | $1,674,320,804 | 3 qtrs |
| Nextech Invest Ltd | Unchanged | 7,601,087 | 0 | 69.89% | $1,560,199,118 | 7 qtrs |
| JANUS HENDERSON GROUP PLC | Reduced | 7,573,603 | -2,192,893 | 0.66% | $1,555,023,854 | 1 qtr |
| Paradigm Biocapital Advisors LP | Reduced | 6,219,323 | -142,000 | 25.38% | $1,276,578,239 | 11 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- Common Stock
Voting authority reported
- Sole
- 9,511
- Shared
- 0
- None
- 34,821
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.